PATENT CLAIM ANALYSIS

Application Number: 15993287
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["514", "04400A"]

Abstract:
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 52 skipping are described.

Claim (Index 8):
The antisense oligomer conjugate of  claim 6 , wherein the antisense oligomer is of Formula (IIA): wherein each Nu from 1 to 25 and 5\u2032 to 3\u2032 is: Position Position Position Position Position No. 5\u2032 No. 5\u2032 No. 5\u2032 No. 5\u2032 No. 5\u2032 to 3\u2032 Nu to 3\u2032 Nu to 3\u2032 Nu to 3\u2032 Nu to 3\u2032 Nu 1 C 6 C 11 X 16 C 21 X 2 X 7 C 12 C 17 A 22 X 3 G 8 A 13 C 18 X 23 G 4 X 9 A 14 X 19 X 24 C 5 X 10 A 15 G 20 G 25 C and wherein A is C is G is and each X is independently

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13219401', '14240832', '14368307', '15339069', '13307926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8142322269058869
- 35 USC 102 Novelty (BERT): 0.5453168209052466
- Combined Prediction Score: 0.7873406863058229
- Mean Citation Score: 388.39622
- Max Citation Score: 426.69928
- Similarity Product: 288.85686581366537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test